We are live on ! Find out more
ONCS

OncoSec Medical

Delisted

ONCS was delisted on the 23rd of June, 2023.

34 hedge funds and large institutions have $7.3M invested in OncoSec Medical in 2017 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 1

292% more capital inflows, than outflows

Capital inflows: $5.78M | Capital outflows: $1.47M

280% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 5

70% more funds holding

Funds holding: 20 → 34 (+14)

12.55% more ownership

Funds ownership: 8.65% → 21.2% (+13%)

Holders
34
Holders Change
+14
Holders Change %
+70%
% of All Funds
0.77%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
6
Reduced
1
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

ONCS Hedge Fund Activity: Q4 2017 in Review

34 of the 4,421 institutional investors tracked by Wall St. Rank reported a position in OncoSec Medical (ONCS) for Q4 2017, worth a combined $7.3M — up 316% from $1.75M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new ONCS positions and 5 closed out — a net gain of 14 holders — while 6 added to existing stakes and 1 trimmed.

The largest buyer was Point72 Asset Management, opening a new position worth an estimated $3.47M. The largest seller was Sabby Management, cutting an estimated $1.36M.

  • 34 institutional investors held OncoSec Medical (ONCS) as of Q4 2017, up from 20 in Q3 2017.
  • Funds reported $7.3M of OncoSec Medical stock for Q4 2017, up 316% quarter-over-quarter.
  • 19 funds opened new OncoSec Medical positions in Q4 2017 and 5 closed out, a net change of +14 holders.
  • The largest OncoSec Medical buyer in Q4 2017 was Point72 Asset Management, an estimated $3.47M added.
  • The largest OncoSec Medical seller in Q4 2017 was Sabby Management, an estimated $1.36M sold.

Based on aggregated 13F filings for Q4 2017.